From April 1st, 2013, to March 31st, 2014, 77 healthcare facilities took part on a voluntary basis in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,149,763 patient-days (Table 1). Participating facilities reported 2,689 BSIs in 2,495 patients. The total incidence rate was 5.4 cases per 10,000 patient-days. The incidence rate in 2013-2014 was significantly lower compared with the average rate for 2009-2013 in facilities that took part in both surveillance periods. Two teaching and 11 non-teaching facilities that were not included in the 2012-2013 study joined the program in 2013-2014. Data was extracted on May 15th, 2014.
Surveillance provinciale des infections nosocomiales
-
March-09-17
-
March-08-17
From April 1st, 2013, to March 31st, 2014, 70 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 132,376 catheter-days (Table 1). Participating ICUs reported 165 CLABSIs in 149 patients. Incidence rates were 0.65 per 1,000 catheter-days in coronary ICUs, 0.71 in teaching adult ICUs, 0.77 in non-teaching adult ICUs, 2.48 in pediatric ICUs and 4.01 in neonatal ICUs. The incidence rates in 2013‑2014 were lower compared to 2009-2013 in teaching and non-teaching adult ICUs as well as in neonatal ICUs while pediatric and coronary ICUs pooled mean rates remained statistically stable. Compared to 2012-2013, two adult non-teaching ICUs with less than 10 beds and a neonatal ICU joined...
-
March-03-17
From April 1st, 2015, to March 31st, 2016, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,717 patient-periods (Table 1), slightly less than the preceding year. Participating units reported 136 VARBSIs in 129 patients. Patient-periods involving a fistula account for 41.0% of patient-periods. The 2015-2016 VARBSI incidence rates are 0.06 cases per 100 patient-periods for patients with an arteriovenous (AV) fistula, 0.32 for patients with a synthetic fistula (graft), 0.33 for patients with a permanent catheter and 3.34 for patients with a temporary catheter. In 2015–2016, incidence rates are significantly lower than in 2011-2015. This decrease is...
-
March-03-17
From April 1st, 2015, to March 31st, 2016, 66 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 128,035 catheter-days (Table 1). Participating ICUs reported 150 CLABSIs in 139 patients. Incidence rates are 0.70 per 1,000 catheter-days in teaching adult ICUs, 0.42 in non-teaching adult ICUs, 1.95 in pediatric ICUs and 4.15 in neonatal ICUs (including cases with a mucosal barrier injury). No case is observed in coronary ICUs. Compared to 2014-2015, a coronary ICU and a teaching ICU stopped participating, while a neonatal ICU joined surveillance; one teaching and one non-teaching ICU that participated in 2014-2015 but provided less than 11 periods of data in 2015-2016, are not...
-
March-03-17
From April 1st, 2015, to March 31st, 2016, 87 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,770,053 patient-days (Table 1). Participating facilities reported 3,173 BSIs in 2,948 patients. The total 2015-2016 incidence rate is 5.45 cases per 10,000 patient-days for all facilities participating in 2015-2016, and it is 5.35 for facilities that participated in 2015-2016 as well as in at least one year between 2011-2012 and 2014-2015. No non-catheter-related primary bloodstream infection (non-CRBSI) with a mucosal barrier injury (MBI) is observed in 2015-2016. The 2015-2016 incidence rate shows a decrease compared to the 2011-2015 incidence rate. A minimum of 11 periods of data are to be...
-
March-01-17
From April 1, 2015, to March 31, 2016, 73 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,749,277 patient days (Table 1). In total, four CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000 patient days. The acquisition rate of healthcare-associated CPGNB colonization (cat. 1a and 1b) was 0.197 per 10,000 patient days. Two teaching facilities and three non-teaching facilities participating last year did not participate this year whereas one teaching and nine non-teaching facilities were...
-
February-28-17
From April 1, 2015, to March 31, 2016, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,833,086 patient days (Table 1). In total, 78 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10,000 patient days. This incidence rate was stable since 2014-2015. The acquisition rate of healthcare-associated VRE colonization (cat. 1a and 1b) in 2015-2016 was 9.76 per 10,000 patient days. For all results, only facilities that participated in at least 11 periods are included in the analyzes. Data was...
-
February-28-17
From April 1, 2015, to March 31, 2016, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,851,752 inpatient days (Table 1). Together, these facilities reported 65 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI). The incidence rate was 0.13 per 10,000 patient-days. This incidence rate of HA-MRSA-BSI has declined over the past five years. The proportion of methicillin resistance in healthcare-associated S. aureus bloodstream infections was 12.6%. Data was extracted on May 31st, 2016. For all results, only facilities that participated in at least 11 periods are included in analyzes. This year, new healthcare facility...
-
September-30-16
The Institut national de santé publique du Québec (INSPQ) [Québec’s public health institute] has been mandated by the Ministère de la Santé et des Services sociaux (MSSS) [Québec’s ministry of health and social services] to oversee the provincial surveillance of healthcare-associated (HA) infections. The Comité sur les infections nosocomiales du Québec (CINQ) [Québec healthcare-associated infections committee] and the Comité de surveillance provinciale des infections nosocomiales (SPIN) [Provincial committee for surveillance of healthcare-associated infections] have set up a structured surveillance program to support public health administrations and local infection prevention and control teams in general as well as specialized acute healthcare facilities.
The data for 2014–...
-
August-29-16
Ce document est un outil de consultation qui vous guidera pas à pas dans l’utilisation du système d’information pour la surveillance provinciale des infections nosocomiales (SI-SPIN) afin de satisfaire les programmes de surveillance suivants :
- Surveillance provinciale des bactériémies à Staphylococcus aureus (BAC-SA);
- Surveillance des souches de Staphylococcus aureus résistantes à la méthicilline (SARM) isolées d’hémocultures;
- Surveillance provinciale des infections à entérocoque résistant à la vancomycine (ERV);
- Surveillance provinciale des infections à bacilles Gram négatif producteurs de carbapénémases (BGNPC);
- Surveillance provinciale des diarrhées associées au Clostridium difficile (CD);
- ...
Pages
